Albert Assad, MD
Incyte Corporation
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Albert Assad, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:59 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT06585774 · A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host DiseaseIncyte Corporation · recruiting · Chronic Graft-versus-host-disease · study director
- Ph2NCT03123588 · Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)Incyte Corporation · terminated · MPN (Myeloproliferative Neoplasms) · study director
- Ph2NCT02723994 · A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic LeukemiaIncyte Corporation · completed · Leukemia · study director
- Ph2NCT02718300 · A Study of INCB050465 in Combination With Ruxolitinib in Subjects With MyelofibrosisIncyte Corporation · terminated · MPN (Myeloproliferative Neoplasms) · study director
- Ph2NCT01633372 · An Open Label Study of Itacitinib Administered Orally in Patients With MyelofibrosisIncyte Corporation · completed · MPN (Myeloproliferative Neoplasms) · study director
- Ph2NCT00726232 · Study to Determine the Safety and Efficacy of INCB018424 in Patients With Polycythemia Vera or Essential ThrombocythemiaIncyte Corporation · terminated · Myeloproliferative Neoplasm (MPN) · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:59 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.